BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2025 8:03:22 AM | Browse: 59 | Download: 215
 |
Received |
|
2025-06-16 01:53 |
 |
Peer-Review Started |
|
2025-06-16 01:53 |
 |
First Decision by Editorial Office Director |
|
2025-06-26 08:25 |
 |
Return for Revision |
|
2025-06-26 08:25 |
 |
Revised |
|
2025-06-30 17:08 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-10-14 02:49 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-10-15 04:05 |
 |
Articles in Press |
|
2025-10-15 04:05 |
 |
Edit the Manuscript by Language Editor |
|
2025-10-19 18:57 |
 |
Typeset the Manuscript |
|
2025-12-16 00:20 |
 |
Publish the Manuscript Online |
|
2025-12-23 08:03 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Minireviews |
| Article Title |
Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Swathi Pandey, Arul Senghor Kadalangudi Aravaanan, Emmanuel Bhaskar and Santhi Silambanan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Santhi Silambanan, MD, Professor, Department of Biochemistry, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai 600116
India, Chennai 600116, Tamil Nādu, India. santhisilambanan@sriramachandra.edu.in |
| Key Words |
Urinary tract infection; Pathogens; Diagnosis; antibiotic sensitivity; Host-derived biomarkers; Pathogen-derived biomarkers; Point-of-care testing; Sustainable development goals 3; Sustainable development goals 8 |
| Core Tip |
Urinary tract infections (UTIs) are prevalent and often require timely diagnosis to prevent complications. The emerging urinary biomarkers, including neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, interleukin (IL)-6, IL-8, heparin-binding protein, procalcitonin, lipopolysaccharide-binding protein, xanthine oxidase, cell-free DNA, and transrenal DNA, have shown potential in identifying infection severity, organ dysfunction, and antibiotic resistance. The review further examines how integrating these biomarkers with advanced biosensor-based diagnostic tools can enhance diagnostic sensitivity, facilitate point-of-care testing, and improve clinical outcomes. The review also underscores the importance of validating and standardizing biomarker-based diagnostics to bridge laboratory innovations with clinical application, ultimately supporting more accurate, rapid, and personalized UTI management. |
| Publish Date |
2025-12-23 08:03 |
| Citation |
Pandey S, Aravaanan ASK, Bhaskar E, Silambanan S. Biomarkers innovation in urinary tract infections: Insights into pathophysiology, antibiotic resistance, and clinical applications. World J Nephrol 2025; 14(4): 110749 |
| URL |
https://www.wjgnet.com/2220-6124/full/v14/i4/110749.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v14.i4.110749 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.